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Abstract
In most adult epithelia the process of replacing damaged or dead cells is maintained through the
presence of stem/progenitor cells, which allow epithelial tissues to be repaired following injury.
Existing evidence strongly supports the presence of stem cells in the adult kidney. Indeed, recent
findings provide evidence in favour of a role for intrinsic renal cells and against a physiological role
for bone marrow-derived stem cells in the regeneration of renal epithelial cells. In addition, recent
studies have identified a subset of CD24+CD133+ renal progenitors within the Bowman's capsule
of adult human kidney, which provides regenerative potential for injured renal epithelial cells.
Intriguingly, CD24+CD133+ renal progenitors also represent common progenitors of tubular cells
and podocytes during renal development. Chronic injury causes dysfunction of the tubular epithelial
cells, which triggers the release of fibrogenic cytokines and recruitment of inflammatory cells to
injured kidneys. The rapid interposition of scar tissue probably confers a survival advantage by
preventing infectious microorganisms from invading the wound, but prevents subsequent tissue
regeneration. However, the existence of renal epithelial progenitors in the kidney suggests a
possible explanation for the regression of renal lesions which has been observed in experimental
animals and even in humans. Thus, manipulation of the wound repair process in order to shift it
towards regeneration will probably require the ability to slow the rapid fibrotic response so that
renal progenitor cells can allow tissue regeneration rather than scar formation.
Background
Most epithelia need to constantly replace damaged or
dead cells throughout life. The process of continual cell
replacement is critical for the maintenance of adult tissues
and is typically maintained through the presence of stem
cells. Stem cells are functionally defined by their ability to
self-renew and to differentiate into the cell lineages of
their tissue of origin [1]. Once activated, epithelial stem
cells can generate proliferating progeny, which are often
referred to as transiently amplifying cells. In their normal
environment, transiently amplifying cells will divide
actively for a restricted period of time, expanding the cel-
lular pool that will then differentiate along a particular
cell lineage to make the tissue. The physiological replace-
ment of cells varies substantially among different epithe-
lia. The epithelium of the intestine completely self-renews
within around 5 days. By contrast, interfollicular epider-
mis takes approximately 4 weeks to renew, whereas the
lung epithelium can take as long as 6 months to be
replaced. In addition some epithelia, such as hair follicles,
present a cyclic mode of cell replacement [1]. Similarly,
the mammary gland proceeds through cycles of growth
and degeneration during and following pregnancy [1]. In
addition, stem cells are critically involved in regeneration
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cells are permanently damaged, most epithelia are able to
repair their tissues following injury [1]; when epithelial
stem cells are depleted, fibrotic responses occur [1].
Do renal stem/progenitor cells exist in the adult kidney?
The understanding of kidney repair is still in its infancy
despite the rapid advances made in recent years. The kid-
ney is one of the few organs that undergo mesenchymal-
epithelial transition during development [2]. Moreover,
structures present in the adult kidney arise from reciprocal
interactions between two discrete embryonic appendages,
namely the ureteric bud (UB) and metanephric mesen-
chyme (MM) [2]. The adult kidney contains more than 24
mature cell types arranged in distinct vascular, interstitial,
glomerular and tubular compartments [2]. This unique
organogenesis and structural complexity of the adult kid-
ney has presented many challenges to the identification
and characterization of kidney stem cells [2,3]. Attempts
to identify adult kidney stem cells were made on the basis
of the broad principles of stem cell biology, such as pro-
longed cell-cycling time (label-retaining cells), ability to
extrude Hoechst dye (side population cells), by restrictive
cell culture conditions, or by using markers expressed by
other stem cells or developing kidney [3]. Existing evi-
dence strongly supports the presence of stem cells in the
adult kidney. Indeed, remission of disease and regression
of renal lesions have been observed in experimental ani-
mals and even in humans [4]. Identification and knowl-
edge of renal stem cell biology might help to unlock latent
regenerative pathways in human kidney, which would
have the potential to change medical practice as much as
the introduction of dialysis did in the twentieth century.
The origin of the cells that replace injured tubular epithe-
lia is not known [3,5], although several lines of evidence
suggest an intrarenal source [6,7]. Recently, putative adult
kidney stem cells have been isolated, with some evidence
indicating that they may enable epithelial repair after
injury [8-18]. Several studies have suggested the existence
of an interstitial renal stem cell. One way of looking for
stem cells in solid organs was a pulse of bromodeoxyuri-
dine (BrdU) followed by a long chase period. The quies-
cent stem cells, which do not divide, maintain the high
levels of BrdU deposited in their genomes, whereas the
dividing, more differentiated stem cells steadily dilute the
BrdU incorporated into their genomes as they proliferate.
Maeshima et al. [12,13] identified BrdU-labelled cells,
which they termed renal progenitor-like tubular cells, in
the renal tubules. Oliver et al. [14] identified a population
of BrdU-label-retaining cells within the interstitium of
renal papilla in the rat kidney. However, the use of BrdU
labelling does not seem to be a specific method for iden-
tification of stem cells [16].
Other studies have identified a rare population of adult
interstitial cells in rat or human kidney [8,9], and such
cells have been proposed to engraft into tubules of either
developing or injured kidney tissue [8,9], suggesting that
extratubular cells can traverse the basement membrane
and contribute to epithelium [14]. Although intriguing,
this hypothesis has recently been questioned by a study by
Humphreys et al. who have developed a method for dis-
tinguishing the source of kidney tubular regeneration
based on studies in transgenic rodents for the homeodo-
main transcriptional regulator Six2 [18]. In this model,
the Six2 promoter drives a fusion protein of green fluores-
cent protein (GFP) and Cre recombinase, which is
expressed transiently in renal epithelial precursors during
the developmental period of active nephrogenesis [18].
GFPCre expression is not present in the adult, and this
expression is not observed after injury. When Six2-GFPCre
mice are crossed with a floxed STOP reporter strain, Cre-
dependent removal of the stop sequence in progeny leads
to constitutive and heritable expression of a marker gene
such that all mesenchyme-derived renal epithelial cells,
from the Bowman's capsule to the junction of the con-
necting segment and collecting duct, are heritably labelled
[18]. In contrast, the entire interstitial compartment is
unlabelled [18]. Thus, the maintenance of labelled
tubules post-injury would support a model of epithelial
tubule repair due to surviving tubular epithelial cells or
stem/progenitor cells localized within the labelled neph-
ron, while label dilution would implicate an unlabelled,
interstitial stem cell in the repair process. These findings
indicate that papillary interstitial cells [14] or other types
of interstitial stem/progenitor cells [8,9] do not directly
contribute to renal epithelial cells regeneration. These
observations also indicate that repair of injured nephrons
is predominantly accomplished by intrinsic, surviving
tubular epithelial cells or a subset of stem/progenitor cells
localized within the nephron [18].
Recent studies identified a subset of renal stem/progenitor
cells within the Bowman's capsule of adult human kidney
[15]. These renal progenitors were identified through the
assessment of the presence of both CD24, a surface mole-
cule that has been used to identify different types of
human stem cells [19,20] and CD133, a marker of several
types of adult tissue stem cells [21,22]. The results showed
that both markers were co-expressed by a subset of pari-
etal epithelial cells selectively localized at the urinary pole
of the Bowman's capsule [15] (Figure 1). Once isolated,
CD24+CD133+ renal progenitors were found to lack line-
age-specific markers; to express transcription factors that
are characteristic of multipotent stem cells, and to exhibit
self-renewal, high clonogenic efficiency, and multidiffer-
entiation potential [15]. When injected intravenously in
SCID mice that had acute renal failure (ARF),Page 2 of 10
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structures in different portions of the nephron and also
reduced the morphological and functional kidney dam-
age [15]. The identification of CD24+CD133+ renal pro-
genitors is in agreement with results obtained in
transgenic mice, which suggests that endogenous cells of
the nephron are responsible for repair of injured tubular
epithelium [18], and allows the hypothesis that, from the
urinary pole of the Bowman's capsule, CD24+CD133+
renal progenitors might initiate the replacement and
regeneration of tubular epithelial cells in adult human
kidney [15] (Figure 2).
Is there a unique renal progenitor common to renal 
development and the repair of adult kidney?
Regenerative biology draws on the understanding of nor-
mal developmental processes. It is generally believed that
adult stem/progenitor cells represent a residual popula-
tion directly derived from the organ-specific embryonic
progenitor that is involved in organogenesis during fetal
life [23-25]. This prompted us to evaluate whether co-
expression of CD133 and CD24 might be useful to track
down multipotent kidney stem/progenitor cells during
human embryonic life.
Nephrons, the basic functional units of the kidney, are
generated repetitively during kidney organogenesis from a
mesenchymal progenitor population. Development of
the mature mammalian kidney results from reciprocal sig-
nalling between the branching UB tips and the undiffer-
entiated MM. This leads to the aggregation and
condensation of renal epithelia progenitor cells to form
the renal vesicle, which then undergoes transformation in
the S-shaped body [2]. At this stage, the proximal end of
the S-shaped body becomes invaded by blood vessels, dif-
ferentiates into podocytes and parietal epithelial cells, and
then generates glomeruli. Simultaneously, the middle and
the distal segments of the S-shaped body begin to express
proteins that are characteristic of tubular epithelia [2]. The
existence of renal embryonic progenitors in the MM is
supported by the observation that some MM-derived cells
display multidifferentiation potential [2,26-28]. Accord-
ingly, in embryonic human kidneys, co-expression of
CD133 and CD24 characterizes a subset of cells in the cap
mesenchyme, renal vesicles and S-shaped bodies that dis-
play self-renewal and multidifferentiation potential (Fig-
ure 1).
Interestingly, during nephron development, co-expres-
sion of CD133 and CD24 remained selectively localized
to cells of the urinary pole of the Bowman's capsule [28].
Accordingly, CD24+CD133+ renal embryonic progenitors
progressively decreased during gestation and represented
< 2% of whole cells in adult kidneys [15,28]. When
injected into mice with ARF, CD24+CD133+ renal embry-
onic progenitors regenerated cells of different portions of
the nephron, reduced tissue necrosis and fibrosis, and sig-
nificantly improved renal function [28]. In agreement
with the putative nature of stem/progenitor cells,
CD24+CD133+ renal embryonic progenitors expressed
high levels of the stem cell-specific transcription factor
BmI-1 [29,30] and could generate tubular cells of different
portions of the nephron in a model of acute tubular
necrosis [28]. The existence of a putative MM cell with
stem cell properties was already suggested by studies per-
formed by the group of Reisner [31], who demonstrated
that functioning renal tissue can be reconstituted by MM
derived from kidneys of 8 weeks of gestation [31]. Indeed,
fetal kidney tissue obtained from 10 to 14 weeks of gesta-
tion maintains the property to generate de novo functional
nephrons, but generates a smaller number of mature
glomeruli and tubuli than kidneys of 8 weeks of gestation
[31]. Accordingly, CD24+CD133+ renal embryonic pro-
genitors are enriched in kidneys of 8 to 9 weeks of gesta-
tion, substantially decrease during 10 to 14 weeks of
CD24+CD133+ renal progenitors localize at the urinary pole of the Bowman's capsule in adult human kidneysFigure 1
CD24+CD133+ renal progenitors localize at the uri-
nary pole of the Bowman's capsule in adult human 
kidneys. (A) Triple-label immunofluorescence for CD133, 
(green), CD24 (red) and β1 integrin (blue) showing that in a 
mature glomerulus, co-expression of CD133 and CD24 
characterizes a subset of cells in the Bowman's capsule 
(white) localized at the urinary pole (UP). AA = afferent arte-
riola. Objective 20×. (B) High power magnification of a triple-
label immunofluorescence for CD133, (green), CD24 (red) 
and CD106 (blue) in a subset of cells in the Bowman's cap-
sule (white). Sections were stained as previously reported 
[15].Page 3 of 10
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adults.
It is interesting that in both fetal and adult kidney,
CD24+CD133+ progenitors persist as parietal epithelial
cells localized at the urinary pole of the Bowman's cap-
sule, supporting the concept that CD24+CD133+ progeni-
tors might represent a subpopulation of renal embryonic
progenitors preserved from the early stages of nephrogen-
esis, and the urinary pole of the Bowman's capsule may
represent stem cell niche, which is a specific site in adult
tissues where stem cells reside (Figure 1) [32]. In agree-
ment with this hypothesis, embryonic stem cells, once dif-
ferentiated toward renal tubular cells, selectively migrated
to the tubuloglomerular junction after injection into
developing kidneys [17]. More recently, studies per-
formed in transgenic rodents for the homeodomain tran-
scriptional regulator Six2 have confirmed the existence in
the cap mesenchyme of a multipotent nephron progeni-
tor population [33]. Indeed, Six2-expressing cells give rise
to all cell types of the main body of the nephron during
all stages of nephrogenesis [34]. Pulse labeling of Six2-
expressing nephron progenitors at the onset of kidney
development suggests that the Six2-expressing population
is maintained by self-renewal and is multipotent, generat-
ing the multiple domains of the whole cortical nephron
[34]. Notably, descendants of a Six2+ cell can be found
within molecularly distinct compartments of a single
nephron – podocytes, proximal and distal tubule struc-
tures – further confirming that a single multipotent pro-
genitor is the source of both the glomerular and tubular
epithelial cells that constitute the adult nephron [34].
Do bone marrow-derived cells contribute to tissue repair?
Some studies have suggested that cells from bone marrow
might possess a surprising degree of plasticity and could
differentiate into cell types of multiple organs of the body
[33,35-38]. Accordingly, it was claimed that bone mar-
row-derived stem cells (BMSC) could contribute to the
generation of new epithelial cells in functionally impor-
tant numbers after kidney injury [39,40]. In light of their
ease of accessibility, BMSC seem to be a very strong candi-
Hypothetical diagram for kidney regeneration by different types of renal and extrarenal progenitorsFigure 2
Hypothetical diagram for kidney regeneration by different types of renal and extrarenal progenitors. 
CD24+CD133+ renal progenitors (red) are localized at the urinary pole and are in close contiguity with podocytes (green) at 
one extremity (the vascular stalk) and with tubular renal cells (yellow) at the other extremity. A transitional cell population 
(red/green) displays features of either renal progenitors (red) or podocytes (green) and localizes between the urinary pole and 
the vascular pole. At the vascular stalk of the glomerulus, the transitional cells are localized in close continuity with cells that 
lack progenitor markers, but exhibit the podocyte markers and the phenotypic features of differentiated podocytes (green). 
On the opposite side, at the urinary pole, transitional cells (red/yellow) with a mixed phenotype between tubular cells (yellow) 
and progenitor cells (red). The directions of differentiation is indicated by the arrows (modified from [24]).Page 4 of 10
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quent studies have examined this possibility, with
contrasting results [40-60].
Sugimoto and colleagues demonstrated that in a mouse
model for Alport syndrome, bone marrow cells contribute
to the emergence of viable podocytes which are associated
with the production of new basement membrane [47]. In
addition, unfractionated BMSC can differentiate into
endothelial and mesangial cells in a model of progressive
glomerulosclerosis [42,44] and, more surprisingly, they
can form new tubular epithelial cells in functionally
important numbers after kidney injury [43]. It has
recently become clear that BMSC might fuse with differen-
tiated cells in various adult organs, further complicating
the interpretation of marrow transplantation studies [61].
Held and co-workers have shown that cell fusion could be
induced between bone marrow-derived cells and renal
tubular cells under conditions of chronic renal damage
[60], apparently without impairment of cell division or
conferment of genetic instability [44,62]. Additional
works by several groups have shown that tubular cell
replacement with BMSC is much lower than originally
reported, calling into question the concept that BMSC
physiologically participate in the repair of kidney injury
[47-57]. Importantly, the low rate of functional improve-
ment observed when using unfractionated BMSC suggests
that in acute tubular injury, regenerating cells originated
from intrarenal cells [6,7]. Accordingly, the absence of
label dilution in Six2-GFPCre mice after injury and repair
confirms that bone marrow-derived cells do not directly
contribute to repair of tubular epithelial cells [18]. Taken
together, these findings provide strong evidence against a
physiological role for BMSC-derived cells in regeneration
of post-ischaemic tubules by direct replacement of epithe-
lial cells.
However, several studies indicate that mesangial cells
might originate from a component of the hematopoietic
lineages [62-65], and that BMSC might largely contribute
to the regeneration of mesangial cells. Imasawa et al. [44]
demonstrated the involvement of bone marrow-derived
cells in normal mesangial cell turnover. Lethally irradiated
mice given transplants of T-cell-depleted bone marrow
cells from syngeneic donor transgenic for GFP manifested
a time-dependent increase in GFP-positive cells in their
glomeruli. When isolated and cultured, these cells stained
positive for the mesangial cell marker desmin and the cells
contracted in response to angiotensin II (Ang II), confirm-
ing that bone marrow-derived cells have the potential to
differentiate into glomerular mesangial cells. Similar
experiments with mice transplanted with purified clonally
expanded hematopoietic progenitor cells were carried out
by Masuya et al. [62] to confirm the hematopoietic origin
of bone marrow-derived mesangial cells.
Finally, several studies have provided evidence that circu-
lating endothelial progenitor cells (EPC) may contribute
to glomerular capillary repair. In rat hematopoietic chi-
meras, low levels of bone marrow-derived cells staining
for the rat endothelial cell antigen RECA-1 [66] were
observed and the number of these cells gradually
increased over time, suggesting that EPC contribute to
normal physiological glomerular endothelial cell turno-
ver. Following anti-Thy-1.1-induced glomerular injury the
authors observed a fourfold increase in bone marrow-
derived endothelial cells in the glomeruli [66]. These data
indicate that glomerular repair cannot only be attributed
to migration and proliferation of resident endothelial
cells but it also involves bone marrow-derived cells.
Participation of circulating EPC in renal regeneration has
also been demonstrated in human adults. Williams and
Alvarez [67] were the first to describe the presence of
acceptor endothelial cells in kidney allografts. Lagaaij et
al. [68] reported that in human renal transplants the
extent of replacement of donor endothelial cells lining the
peritubular capillaries by those of the acceptor was related
to the severity of vascular injury. They suggested that this
endothelial replacement could be explained by the
involvement of acceptor-derived EPC. Recently, male,
donor-derived endothelial cells were observed in the renal
macrovasculature of a female patient who developed
thrombotic microangiopathy after gender-mismatched
bone marrow transplantation [69]. Taken together, these
observations confirm a role for BMSC in maintenance and
repair of renal mesangium and endothelium, but not of
the epithelial components of renal tissue.
Towards the understanding of renal tissue regeneration
Tissue stem cells can form various lineages in response to
physiological stimuli or injuries, a property that has great
potential for regenerative medicine approaches. However,
in many cases repair of epithelial cells does not depend on
cells generated from multipotent stem cells, but directly
derives from the migration of epithelial cells from the
neighbouring epithelia, as previously reported also for the
skin [70,71]. Indeed, genetic analyses suggest that the
tubular epithelium can be self-renewing after acute kidney
injury. Interestingly however, several previous studies
have demonstrated that the proximal tubule arises at a
variety of angles from Bowman's capsule and that at least
one part of the tubuloglomerular junction has an area of
intermediate appearance, with prominent microvilli on
parietal cells in humans, mammals and fish. The finding
of intermediate cells, especially in growing animals, sug-
gests that parietal epithelium may be able to change to
tubular and that this might particularly occur as the kid-
ney grows, during severe renal disorders [72-75], follow-
ing unilateral nephrectomy [76] or during ageing [77].
Thus, renal stem/progenitor cells might contribute toPage 5 of 10
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when a wound cannot spontaneously repair itself through
the migration of neighbouring undamaged tubular cells
(Figure 2).
Indeed, mice affected by rhabdomyolysis-induced acute
tubular necrosis spontaneously recover from acute kidney
injury, but mice undergoing early treatment with human
renal progenitors show a complete recovery of renal func-
tion and kidney tissue integrity that was not observed in
mice treated with saline [15] and, more importantly, a sig-
nificant reduction of the severity of ARF, as revealed by the
consistently lower blood urea nitrogen levels and
extended areas of tubular tissue regenerated by human
renal progenitors that co-expressed markers of proximal
and distal tubules. This suggests that CD24+CD133+ pro-
genitors can regenerate tubular cells of different portions
of the nephron, in vitro and in vivo [78,79]. However, the
most important goal of regenerative medicine in the kid-
ney is regeneration of glomerular injury, since glomerular
diseases together account for 90% of end-stage kidney dis-
ease (ESKD).
Recent insights have defined a unified concept of glomer-
ular diseases in which podocyte injury or loss is a com-
mon determining factor, which suggests the need for
rational clinical efforts to allow podocyte regeneration
[80-82]. Mature podocytes are post-mitotic cells, which
can undergo DNA synthesis to a limited degree but do not
proliferate, because they arrest in the G2/M phase of the
cell cycle [80-82]. However, in most adult epithelia,
replacement of damaged or dead cells is maintained
through the presence of stem/progenitor cells [1]. Unless
the epithelial stem/progenitor cells are permanently dam-
aged, most epithelia are able to repair their tissues follow-
ing injuries [1]. Although glomerular disorders represent
the most prominent cause of ESKD, remission of the dis-
ease and regression of renal lesions have been observed in
experimental animals and even in humans [3]. This shows
that remodelling of glomerular architecture is possible,
which would imply regeneration of the injured podocytes
and reconstitution of the glomerular tuft. The inability of
the podocyte to proliferate and replace injured cells sug-
gests the existence of potential stem/progenitor cells
within the adult glomerulus. Interestingly, CD24+CD133+
Hypothetical diagram for kidney fibrosisFigure 3
Hypothetical diagram for kidney fibrosis. Chronic injury causes dysfunction of the tubular epithelial cells, which triggers 
release of fibrogenic cytokines and recruitment of inflammatory cells to injured kidneys. Myelo-monocytic cells recruited from 
the bone marrow produce TGF-β1 in injured kidneys. In turn, TGF-β1 induces activation of collagen-producing cells, which 
mostly arise from kidney resident cells through epithelial-mesenchymal transition (modified [24]).Page 6 of 10
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man's capsule, the only place in the kidney which appears
to be contiguous with both tubular cells and glomerular
podocytes [15]. Previous studies have suggested the exist-
ence of transitional cells exhibiting a mixed phenotype
between the parietal epithelial cells and the podocyte at
the vascular pole of the glomerulus [83]. In addition,
CD24+CD133+ renal progenitors represent common pro-
genitors of tubular cells and podocytes during renal devel-
opment [29]. Accordingly, recent studies performed in
our laboratory suggest that CD24+CD133+ renal progeni-
tors can also regenerate glomerular podocytes in mice
affected by adriamycin nephropathy, and can reduce the
severity of proteinuria and of glomerular injury [84].
These results suggest that CD24+CD133+ renal progeni-
tors can also replace and regenerate podocytes through
their division and migration along the Bowman's capsule
towards the glomerular tuft during adult life or in
response to podocyte injury (Figure 2).
The response to renal injury: from regeneration to fibrosis
In humans, problems with wound healing can manifest as
either delayed wound healing (which occurs with diabetes
or radiation exposure) or excessive healing (as occurs with
hypertrophic and keloid scars). Excessive healing is char-
acterized by the deposition of large amounts of extracellu-
lar matrix and by alterations in local vascularization and
cell proliferation. These excessive fibrotic reactions mani-
fest in humans as a 'bad scar'. These commonly occur after
major injuries such as burns, in which case they are
referred to as hypertrophic scars. They can also appear for
unknown reasons after a relatively minor trauma, as is the
case for keloid scars, which might have a genetic basis [85-
87]. Chronic infections, toxic and metabolic injuries, and
idiopathic inflammatory diseases can promote the devel-
opment of a scar, leading to tissue fibrosis [85]. In many
cases, patients with progressive fibrosis have a poor prog-
nosis and often require organ transplantation [85-87].
Although fibrosis is a part of the normal pathophysiolog-
ical response to injury in many tissues, extended exposure
to chronic injury results in tissue fibrosis, massive deposi-
tion of extracellular matrix, scar formation, and organ fail-
ure [87]. Chronic injury causes dysfunction of the tubular
epithelial cells, which triggers release of fibrogenic
cytokines and recruitment of inflammatory cells to
injured kidneys [88-91]. Over the years, the primary focus
of tubulointerstitial fibrosis studies has been on intersti-
tial fibroblasts and infiltrated mononuclear cells for obvi-
ous reasons [92-94]. However, fibroblast activation after
injury is, in essence, a wound-healing response by which
the injured kidney attempts to repair and recover from the
injury. Therefore, fibroblast activation at most may be
necessary, but certainly not sufficient, for development of
a full-scale of renal interstitial fibrosis.
Fibroblasts contribute to 50% of all collagen-expressing
cells in the course of renal fibrosis. Renal cortical fibrob-
lasts maintain a quiescent state in normal kidneys, but in
response to injury they proliferate and activate into myofi-
broblasts. Fibroblasts are not particularly abundant in
normal kidneys as they are in lungs, lymph nodes, and
spleen. When renal fibrogenesis sets in, about 36% of new
fibroblasts come from the local epithelial mesenchymal
transition (EMT), about 14–15% from the bone marrow,
and the rest from local proliferation [94]. Endothelial
cells also contribute to the emergence of fibroblasts dur-
ing kidney fibrosis via the process of EMT, as recently
demonstrated in mouse models of unilateral ureteral
obstructive nephropathy, diabetic nephropathy, and
Alport renal disease [95]. Although local activation of the
renin-angiotensin system (RAS) and specifically Ang II
affects all parenchymal organs, its effect is more pro-
nounced in renal fibrosis. RAS stimulates inflammation,
including the expression of cytokines, chemokines,
growth factors, and reactive oxygen species [94,96]. Ang II
induces vascular inflammation, endothelial dysfunction,
up-regulation of adhesion molecules, and recruitment of
infiltrating cells into the kidney (Figure 3) [94,96].
In addition, myelo-monocytic cells recruited from the
bone marrow produce TGF-β1 in injured kidneys. In turn,
TGF-β1 induces activation of collagen-producing cells,
which mostly arise from kidney resident cells. The poten-
tial role of tubular epithelial cells in renal fibrosis is often
concealed, partly because no direct connection seems to
exist between tubular cells and the production and depo-
sition of extracellular matrix, a hallmark of interstitial
fibrosis. However, molecular analyses of gene expression
have constantly underlined the potential importance of
tubular epithelia in the fibrotic process. For instance,
while it is well known that TGF-β1 expression is increased
in almost all of the chronic kidney disease models stud-
ied, the expression of TGF-β receptors, which determine
the specificity of TGF-β action, is often up-regulated pre-
dominantly in renal tubular epithelium [97], indicating
that tubular epithelial cells are the in vivo natural targets of
this pro-fibrotic cytokine. Hence, EMT helps to reconcile
the disparity between molecular analysis and pathological
findings in fibrotic kidney. Recently, pericytes were also
identified as a major source of interstitial myofibroblasts
in the fibrotic kidney, suggesting that either vascular
injury or vascular factors are the most likely triggers for
pericyte migration and differentiation into myofibrob-
lasts (Figure 3) [98].
The accumulation of fibroblasts and an excess of collagen
and other matrix components at sites of chronic inflam-
mation lead to scar tissue formation and progressive tis-
sue injury. These fibroblasts derive from the bone
marrow, but also arise from an EMT of cells at injury sitesPage 7 of 10
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fibrotic diseases of the heart, lung, liver, and kidney, and
genetic models provide indisputable evidence for a crucial
role for EMT in renal fibrogenesis.
Conclusion
Reversal of renal fibrosis is possible, as observed in exper-
imental animals and even in humans [4]. However,
whether fibrotic kidneys can reverse to normal renal archi-
tecture remains unresolved, and the point of no return in
the development of irreversible renal fibrosis still remains
to be determined. The rapid interposition of scar tissue
probably confers a survival advantage by preventing infec-
tious microorganisms from invading the wound and by
inhibiting the continued mechanical deformation of
larger tissues (a process that could compound the initial
insult), but prevents subsequent tissue regeneration.
However, the existence of renal epithelial progenitors in
the kidney suggests a possible explanation for the regres-
sion of renal lesions, and indicates that a manipulation of
the wound repair process in order to shift it towards
regeneration [99] will probably require the ability to slow
the rapid fibrotic response so that renal progenitor cells
can regenerate functional tissue and avoid scar formation.
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